| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | D'Amore PA | |
| Folkman J | |||
| P2860 | cites work | Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation | Q24316945 |
| Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium | Q28587604 | ||
| Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice | Q28593600 | ||
| Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene | Q29547732 | ||
| Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele | Q29547733 | ||
| Abnormal kidney development and hematological disorders in PDGF beta-receptor mutant mice. | Q33491174 | ||
| An activated form of transforming growth factor beta is produced by cocultures of endothelial cells and pericytes | Q33862469 | ||
| Endothelial receptor tyrosine kinases involved in angiogenesis. | Q40400431 | ||
| Role of tissue factor in embryonic blood vessel development. | Q45878003 | ||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1153-1155 | |
| P577 | publication date | 1996-12-01 | |
| P1433 | published in | Cell | Q655814 |
| P1476 | title | Blood vessel formation: what is its molecular basis? | |
| P478 | volume | 87 |
| Q57819753 | 3D biofabrication of vascular networks for tissue regeneration: A report on recent advances |
| Q36622304 | 3D microvascular architecture of pre-cancerous lesions and invasive carcinomas of the colon |
| Q27340441 | 3D multi-cell simulation of tumor growth and angiogenesis |
| Q51810208 | A Comparative Study of Collagen Matrix Density Effect on Endothelial Sprout Formation Using Experimental and Computational Approaches. |
| Q40692331 | A DNA vaccine against VEGF receptor 2 prevents effective angiogenesis and inhibits tumor growth |
| Q28510897 | A combinatorial role of angiopoietin-1 and orphan receptor TIE1 pathways in establishing vascular polarity during angiogenesis |
| Q28592376 | A murine model of hereditary hemorrhagic telangiectasia |
| Q46609459 | A new animal model for pulmonary hypertension based on the overexpression of a single gene, angiopoietin-1. |
| Q40432028 | A new role of lipid receptors in vascular and cardiac morphogenesis |
| Q22253207 | A non-transmembrane form of Jagged-1 regulates the formation of matrix-dependent chord-like structures |
| Q73409864 | A novel in vitro human model of hemangioma |
| Q44581509 | A quantitative ELISA-based co-culture angiogenesis and cell proliferation assay |
| Q36921737 | A role for cadherin-5 in regulation of vascular endothelial growth factor receptor 2 activity in endothelial cells |
| Q28508896 | A role for hematopoietic stem cells in promoting angiogenesis |
| Q36255171 | A role for tissue factor in cell adhesion and migration mediated by interaction with actin-binding protein 280. |
| Q46233039 | Abnormal pattern of Tie-2 and vascular endothelial growth factor receptor expression in human cerebral arteriovenous malformations |
| Q47967619 | Activation of the HIF pathway in childhood ALL, prognostic implications of VEGF. |
| Q35788937 | Activation of the tie2 receptor by angiopoietin-1 enhances tumor vessel maturation and impairs squamous cell carcinoma growth |
| Q35810840 | Active roles of tumor stroma in breast cancer metastasis |
| Q47130813 | Adenosine Receptors As Drug Targets for Treatment of Pulmonary Arterial Hypertension |
| Q35694622 | Adenovirus-mediated gene transfer of endostatin in vivo results in high level of transgene expression and inhibition of tumor growth and metastases |
| Q47797257 | Age of donor of human mesenchymal stem cells affects structural and functional recovery after cell therapy following ischaemic stroke. |
| Q34996426 | Airway and blood vessel interaction during lung development |
| Q44382901 | Alterations in TGF-beta1 expression in lambs with increased pulmonary blood flow and pulmonary hypertension |
| Q48004267 | Alterations in angiogenic growth factors and neuronal nitric oxide synthase expression in chronic cavernosal ischemia |
| Q33943213 | An anti-angiogenic state in mice and humans with retinal photoreceptor cell degeneration |
| Q36438193 | An essential role for macrophage migration inhibitory factor (MIF) in angiogenesis and the growth of a murine lymphoma. |
| Q46200461 | An imbalance between VEGF and endostatin underlies impaired angiogenesis in gastric mucosa of aging rats |
| Q54638702 | Analysis of gene and protein expression in healthy and carious tooth pulp with cDNA microarray and two-dimensional gel electrophoresis. |
| Q54752508 | Angioarrestin mRNA expression in early-stage lung cancers. |
| Q34107240 | Angiogenesis |
| Q34089126 | Angiogenesis and angiogenic mediators in haematological malignancies |
| Q48799470 | Angiogenesis and cerebral neoplasia |
| Q42164955 | Angiogenesis and myogenesis as two facets of inflammatory post-ischemic tissue regeneration |
| Q33856034 | Angiogenesis as a target for breast cancer therapy |
| Q35038768 | Angiogenesis as a target for cancer therapy |
| Q35553507 | Angiogenesis as a target in rheumatoid arthritis |
| Q31113638 | Angiogenesis by implantation of peripheral blood mononuclear cells and platelets into ischemic limbs |
| Q36349939 | Angiogenesis impairment in Id-deficient mice cooperates with an Hsp90 inhibitor to completely suppress HER2/neu-dependent breast tumors |
| Q38293036 | Angiogenesis in gastric mucosa: an important component of gastric erosion and ulcer healing and its impairment in aging |
| Q36014424 | Angiogenesis in nodal B cell lymphomas: a high throughput study. |
| Q33944071 | Angiogenesis in the corpus luteum. |
| Q35745938 | Angiogenesis in the mouse lung |
| Q36230890 | Angiogenesis: update 2005. |
| Q41079751 | Angiogenic Factor with G-patch and FHA Domain 1 (AGGF1) Expression in Human Vascular Lesions |
| Q40559736 | Angiogenic activity of osteopontin-derived peptide SVVYGLR |
| Q35207666 | Angiogenic factors in the central nervous system |
| Q48748937 | Angiogenic profile of childhood primitive neuroectodermal brain tumours/medulloblastomas |
| Q40604686 | Angioimmunoblastic lymphadenopathy-type peripheral T-cell lymphoma with cutaneous infiltration: report of a case and its gene expression profile |
| Q28640803 | Angiopoietin and Tie signaling pathways in vascular development |
| Q24310303 | Angiopoietin-1 induces sprouting angiogenesis in vitro |
| Q34037478 | Angiopoietin-2 displays VEGF-dependent modulation of capillary structure and endothelial cell survival in vivo |
| Q33914700 | Angiopoietin-3 is tethered on the cell surface via heparan sulfate proteoglycans |
| Q42949636 | Angiopoietin1/Tie2 and VEGF/Flk1 induced by MSC treatment amplifies angiogenesis and vascular stabilization after stroke |
| Q33582933 | Animal models of choroidal and retinal neovascularization |
| Q24564477 | Antisense targeting of perlecan blocks tumor growth and angiogenesis in vivo |
| Q41203587 | Antitumoral effects of γCdcPLI, a PLA2 inhibitor from Crotalus durissus collilineatus via PI3K/Akt pathway on MDA-MB-231 breast cancer cell. |
| Q51212009 | Application of periodontal tissue engineering using enamel matrix derivative and a human fibroblast-derived dermal substitute to stimulate periodontal wound healing in Class III furcation defects. |
| Q28078135 | Aqueous outflow - A continuum from trabecular meshwork to episcleral veins |
| Q47756092 | Arginine deiminase and other antiangiogenic agents inhibit unfavorable neuroblastoma growth: potentiation by irradiation |
| Q36712592 | Assembly of complex cell microenvironments using geometrically docked hydrogel shapes |
| Q33592316 | Association of COL4A1 genetic polymorphisms with coronary artery disease in Uygur population in Xinjiang, China |
| Q38129374 | BDNF and VEGF in the pathogenesis of stress-induced affective diseases: an insight from experimental studies |
| Q92737023 | Balance of interstitial flow magnitude and vascular endothelial growth factor concentration modulates three-dimensional microvascular network formation |
| Q39646992 | Balancing the activation state of the endothelium via two distinct TGF-beta type I receptors |
| Q29622882 | Basement membranes: structure, assembly and role in tumour angiogenesis |
| Q40728141 | Bcr-abl-positive cells secrete angiogenic factors including matrix metalloproteinases and stimulate angiogenesis in vivo in Matrigel implants. |
| Q46167132 | Beneficial effects of sorafenib on splanchnic, intrahepatic, and portocollateral circulations in portal hypertensive and cirrhotic rats |
| Q57470597 | Bioengineering human vascular networks: trends and directions in endothelial and perivascular cell sources |
| Q24563486 | Biologic significance of angiopoietin-2 expression in human hepatocellular carcinoma |
| Q30493703 | Biomimetic hydrogels with pro-angiogenic properties |
| Q45882058 | Blockade of in vivo VEGF-mediated angiogenesis by antisense gene therapy: role of Flk-1 and Flt-1 receptors |
| Q46734958 | Blocking angiogenesis with peptides that inhibit the activity of procollagen C-endopeptidase. |
| Q34489077 | Blood vessel maturation: vascular development comes of age |
| Q35751643 | CD13/APN is activated by angiogenic signals and is essential for capillary tube formation |
| Q92604883 | CD36 tango in cancer: signaling pathways and functions |
| Q28199550 | CEA-related cell adhesion molecule 1: a potent angiogenic factor and a major effector of vascular endothelial growth factor |
| Q61765572 | COX-2 over-expression correlates with VEGF and tumour angiogenesis in canine mammary cancer |
| Q64118296 | CXCL5 induces tumor angiogenesis via enhancing the expression of FOXD1 mediated by the AKT/NF-κB pathway in colorectal cancer |
| Q24647068 | CYR61, a product of a growth factor-inducible immediate early gene, promotes angiogenesis and tumor growth |
| Q42703228 | Cadmium-induced embryopathy: nitric oxide rescues teratogenic effects of cadmium |
| Q28567197 | Calcineurin initiates smooth muscle differentiation in neural crest stem cells |
| Q35918764 | Calpain-mediated vimentin cleavage occurs upstream of MT1-MMP membrane translocation to facilitate endothelial sprout initiation |
| Q26774159 | Cancer-Associated Fibroblasts: Their Characteristics and Their Roles in Tumor Growth |
| Q34055976 | Capillary network patterning during angiogenesis |
| Q47812845 | Cardiovascular and Hemostatic Disorders: SOCE in Cardiovascular Cells: Emerging Targets for Therapeutic Intervention. |
| Q35889110 | Cell and molecular mechanisms of insulin-induced angiogenesis |
| Q34075718 | Cell biology of cardiac development |
| Q41836015 | Cell type-specific expression of angiopoietin-1 and angiopoietin-2 suggests a role in glioblastoma angiogenesis |
| Q34350850 | Cell-cell interactions in vascular development |
| Q37465320 | Cellular and molecular basis of pulmonary arterial hypertension |
| Q36268032 | Cellular and molecular mechanisms of gastrointestinal ulcer healing |
| Q37577494 | Cellular aspects of wound healing |
| Q33861779 | Cellular mechanisms of CNS pericytes |
| Q35026817 | Cellular precursors of the coronary arteries |
| Q41755909 | Characterization of METH-1/ADAMTS1 processing reveals two distinct active forms |
| Q46518985 | Characterization of the integrin alpha v beta3 in arteriovenous malformations and cavernous malformations. |
| Q52189117 | Chimaeric analysis reveals role of Pdgf receptors in all muscle lineages. |
| Q42718470 | Chimera analysis reveals that fibroblasts and endothelial cells require platelet-derived growth factor receptorbeta expression for participation in reactive connective tissue formation in adults but not during development |
| Q35562223 | Classification and imaging of vascular malformations in children |
| Q33777861 | Clonally expanded novel multipotent stem cells from human bone marrow regenerate myocardium after myocardial infarction |
| Q28208656 | Cloning of an immunoglobulin family adhesion molecule selectively expressed by endothelial cells |
| Q35279932 | Comparative evaluation of the antitumor activity of antiangiogenic proteins delivered by gene transfer |
| Q39720193 | Comparison of the effectiveness of gene therapy with transforming growth factor-beta or extracorporal shock wave therapy to reduce ischemic necrosis in an epigastric skin flap model in rats |
| Q73081089 | Comparison of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in SCID mice |
| Q38132173 | Complements and the wound healing cascade: an updated review |
| Q42679515 | Computational flow dynamics in a geometric model of intussusceptive angiogenesis |
| Q26998587 | Concise review: therapeutic potential of adipose tissue-derived angiogenic cells |
| Q82030010 | Congenital vascular malformations in childhood |
| Q92882879 | Constitutive Active Mutant TIE2 Induces Enlarged Vascular Lumen Formation with Loss of Apico-basal Polarity and Pericyte Recruitment |
| Q38715869 | Copper ion interaction with the RNase catalytic site fragment of the angiogenin protein: an experimental and theoretical investigation. |
| Q73840540 | Correlation between neovascularisation and neuroendocrine differentiation in prostatic carcinoma |
| Q84459020 | Correlational study of vascular endothelial growth factor expression and microvessel density in primary malignant gastric lymphoma |
| Q33889677 | Crystal structure of an angiogenesis inhibitor bound to the FGF receptor tyrosine kinase domain. |
| Q42152403 | Crystal structures of the Tie2 receptor ectodomain and the angiopoietin-2-Tie2 complex |
| Q35586182 | Cyclo-oxygenase 2 expression is associated with angiogenesis and lymph node metastasis in human breast cancer. |
| Q64018871 | DNA microarray study on gene expression profiles in co-cultured endothelial and smooth muscle cells in response to 4- and 24-h shear stress |
| Q61771867 | Decorin suppresses tumor cell-mediated angiogenesis |
| Q28510984 | Defective vascularization of HIF-1alpha-null embryos is not associated with VEGF deficiency but with mesenchymal cell death |
| Q34143913 | Delivery of lipoplexes for genotherapy of solid tumours: role of vascular endothelial cells |
| Q41438314 | Developmental ablation of Id1 and Id3 genes in the vasculature leads to postnatal cardiac phenotypes. |
| Q28251854 | Developmental expression of perlecan during murine embryogenesis |
| Q54586398 | Different vascular endothelial growth factor (VEGF), VEGF-receptor 1 and -2 mRNA expression profiles between clear cell and papillary renal cell carcinoma. |
| Q31065769 | Differential expression of splicing variants of the human caldesmon gene (CALD1) in glioma neovascularization versus normal brain microvasculature |
| Q34365504 | Differential regulation of orphan nuclear receptor TR3 transcript variants by novel vascular growth factor signaling pathways |
| Q34457597 | Disruption of angiogenesis by PEX, a noncatalytic metalloproteinase fragment with integrin binding activity |
| Q51776814 | Distribution of EphB4 and EphrinB2 in normal and malignant urogenital tissue. |
| Q33803966 | Down-regulation of vascular endothelial growth factor expression by anti-Her2/neu single chain antibodies. |
| Q42490070 | E-selectin expression and stimulation by inflammatory mediators are developmentally regulated during embryogenesis |
| Q35125076 | EGF-like-domain-7 is required for VEGF-induced Akt/ERK activation and vascular tube formation in an ex vivo angiogenesis assay. |
| Q24545469 | EGFL7 is a chemoattractant for endothelial cells and is up-regulated in angiogenesis and arterial injury |
| Q24629370 | Edg-1, the G protein-coupled receptor for sphingosine-1-phosphate, is essential for vascular maturation |
| Q36383300 | Effect of metformin on the proliferation, migration, and MMP-2 and -9 expression of human umbilical vein endothelial cells |
| Q51642790 | Effect of oxygen and glucose deprivation on VEGF and its receptors in microvascular endothelial cells co-cultured with mast cells. |
| Q30654744 | Effects of collagen gel configuration on behavior of vascular smooth muscle cells in vitro: association with vascular morphogenesis. |
| Q98770909 | Efficacy and safety of bevacizumab in Turkish patients with metastatic and recurrent cervical cancer |
| Q47266928 | Elastic Fibers and Large Artery Mechanics |
| Q24321276 | Elastin is an essential determinant of arterial morphogenesis |
| Q35809742 | Endoglin expression is reduced in normal vessels but still detectable in arteriovenous malformations of patients with hereditary hemorrhagic telangiectasia type 1. |
| Q22008597 | Endoglin is an accessory protein that interacts with the signaling receptor complex of multiple members of the transforming growth factor-beta superfamily |
| Q34341837 | Endoglin promotes angiogenesis in cell- and animal-based models of retinal neovascularization |
| Q73409205 | Endoglin, a TGF-beta receptor-associated protein, is expressed by smooth muscle cells in human atherosclerotic plaques |
| Q40379734 | Endostatin inhibits lymph node metastasis by a down-regulation of the vascular endothelial growth factor C expression in tumor cells |
| Q37209651 | Endothelial and hematopoietic progenitor cells (EPCs and HPCs): hand in hand fate determining partners for cancer cells |
| Q37209074 | Endothelial cell dysfunction and cross talk between endothelium and smooth muscle cells in pulmonary arterial hypertension. |
| Q33947958 | Endothelial cell-specific molecule 2 (ECSM2) localizes to cell-cell junctions and modulates bFGF-directed cell migration via the ERK-FAK pathway |
| Q41694100 | Endothelial cells and angiogenesis |
| Q37316581 | Endothelial-specific expression of WNK1 kinase is essential for angiogenesis and heart development in mice |
| Q38046445 | Endothelialization approaches for viable engineered tissues |
| Q42041659 | Engineering robust and functional vascular networks in vivo with human adult and cord blood-derived progenitor cells. |
| Q36133473 | Equal modulation of endothelial cell function by four distinct tissue-specific mesenchymal stem cells |
| Q36438366 | Establishing a link between oncogenes and tumor angiogenesis |
| Q47554175 | Establishment of a three-dimensional model to study human uterine angiogenesis |
| Q45882455 | Evaluation of endostatin antiangiogenesis gene therapy in vitro and in vivo |
| Q30710195 | Evidence for characteristic vascular patterns in solid tumours: quantitative studies using corrosion casts |
| Q24297582 | Evidence that bone morphogenetic protein 4 has multiple biological functions during kidney and urinary tract development |
| Q46118918 | Expansion and differentiation of human primary osteoblasts in two- and three-dimensional culture |
| Q38520494 | Experimental approaches to vascularisation within tissue engineering constructs. |
| Q32062557 | Expression and purification of human recombinant GST-FGF receptor-1. |
| Q36295017 | Expression of Tie2/Tek in breast tumour vasculature provides a new marker for evaluation of tumour angiogenesis |
| Q45014378 | Expression of VE-cadherin in zebrafish embryos: a new tool to evaluate vascular development |
| Q35787996 | Expression of angiogenesis stimulators and inhibitors in human thyroid tumors and correlation with clinical pathological features |
| Q34327105 | Expression of angiopoietins in renal epithelial and clear cell carcinoma cells: regulation by hypoxia and participation in angiogenesis |
| Q40613308 | Expression of extradomain-B-containing fibronectin in subretinal choroidal neovascular membranes |
| Q35778023 | Expression of heparanase in vascular cells and astrocytes of the mouse brain after focal cerebral ischemia |
| Q44134445 | Expression of the endothelial receptor tyrosine kinase Tie2 in lobular capillary hemangioma of the oral mucosa: an immunohistochemical study |
| Q42008716 | FGFR-1 is required by epicardium-derived cells for myocardial invasion and correct coronary vascular lineage differentiation |
| Q40874501 | Factor VIIa/tissue factor-induced signaling via activation of Src-like kinases, phosphatidylinositol 3-kinase, and Rac. |
| Q33555162 | Fibromodulin promoted in vitro and in vivo angiogenesis |
| Q24554513 | Fisp12/mouse connective tissue growth factor mediates endothelial cell adhesion and migration through integrin alphavbeta3, promotes endothelial cell survival, and induces angiogenesis in vivo |
| Q59081200 | Flk1-positive cells derived from embryonic stem cells serve as vascular progenitors |
| Q35604895 | Fluid shear stress and sphingosine 1-phosphate activate calpain to promote membrane type 1 matrix metalloproteinase (MT1-MMP) membrane translocation and endothelial invasion into three-dimensional collagen matrices |
| Q36563956 | Fluid shear stress modulates endothelial cell invasion into three-dimensional collagen matrices |
| Q33857584 | Functions of mammalian Smad genes as revealed by targeted gene disruption in mice |
| Q42322746 | Gallic Acid Enriched Fraction of Phyllanthus emblica Potentiates Indomethacin-Induced Gastric Ulcer Healing via e-NOS-Dependent Pathway |
| Q43764044 | Gene transfer of the vascular endothelial growth factor receptor flt-1 suppresses pulmonary metastasis associated with lung growth |
| Q36921160 | Genetic Aspects of Cerebrovascular Malformations |
| Q37828670 | Genetic analysis of blood vessel formation role of endothelial versus smooth muscle cells |
| Q40253771 | Genitourinary oncology and its surgeon scientists: triumphant past, but does it have a future? |
| Q51707071 | Granzyme B-truncated VEGF fusion protein represses angiogenesis and tumor growth of OSCC. |
| Q43956506 | Growth inhibition of prostate cancer xenografts by halofuginone |
| Q30828692 | HCPTPA, a protein tyrosine phosphatase that regulates vascular endothelial growth factor receptor-mediated signal transduction and biological activity. |
| Q21131825 | HET0016, a selective inhibitor of 20-HETE synthesis, decreases pro-angiogenic factors and inhibits growth of triple negative breast cancer in mice |
| Q28513845 | HOXA13 Is essential for placental vascular patterning and labyrinth endothelial specification |
| Q35204101 | Hematopoietic stem cell transplantation for cardiac and peripheral vascular disease |
| Q74577410 | Hepatocyte growth factor upregulates thymosin beta4 in human umbilical vein endothelial cells |
| Q33691285 | Hereditary haemorrhagic telangiectasia and pulmonary arteriovenous malformations: issues in clinical management and review of pathogenic mechanisms |
| Q33854081 | Hereditary hemorrhagic telangiectasia: A model for blood vessel growth and enlargement |
| Q42498167 | Heterogeneity of capillary endothelial cells for basic fibroblast growth factor-induced paracrine signaling |
| Q36597611 | Hic-5 mediates the initiation of endothelial sprouting by regulating a key surface metalloproteinase |
| Q81271496 | High level of endostatin in epididymal epithelium: protection against primary malignancies in this organ? |
| Q41959365 | Homeostatic competition drives tumor growth and metastasis nucleation |
| Q33925950 | Human endothelial colony-forming cells serve as trophic mediators for mesenchymal stem cell engraftment via paracrine signaling |
| Q74191607 | Human recombinant tissue factor pathway inhibitor induces apoptosis in cultured human endothelial cells |
| Q35787020 | Hyperglycemia-induced vasculopathy in the murine vitelline vasculature: correlation with PECAM-1/CD31 tyrosine phosphorylation state |
| Q28344343 | Hypoxia-inducible angiopoietin-2 expression is mimicked by iodonium compounds and occurs in the rat brain and skin in response to systemic hypoxia and tissue ischemia |
| Q24320033 | Hypoxia-inducible factor-1 mediates activation of cultured vascular endothelial cells by inducing multiple angiogenic factors |
| Q35848595 | Hypoxic induction of an HIF-1alpha-dependent bFGF autocrine loop drives angiogenesis in human endothelial cells |
| Q40562118 | ICM0301s, new angiogenesis inhibitors from Aspergillus sp. F-1491. I. Taxonomy, fermentation, isolation and biological activities |
| Q28594748 | IL-1 is required for tumor invasiveness and angiogenesis |
| Q37582035 | IL-1β promotes proliferation and migration of gallbladder cancer cells via Twist activation |
| Q30442152 | Identification of a novel marker for primordial smooth muscle and its differential expression pattern in contractile vs noncontractile cells |
| Q24307874 | Identification of an angiogenic factor that when mutated causes susceptibility to Klippel-Trenaunay syndrome |
| Q79149109 | Immature tumor angiogenesis in high-grade and high-stage renal cell carcinoma |
| Q43954037 | Immobilized liposome layers for drug delivery applications: inhibition of angiogenesis. |
| Q35647541 | Impact of stroma on the growth, microcirculation, and metabolism of experimental prostate tumors |
| Q39660448 | Implication of the ERK Pathway on the Post-transcriptional Regulation of VEGF mRNA Stability |
| Q37825180 | In pursuit of new anti-angiogenic therapies for cancer treatment |
| Q38755039 | In vitro imaging of angiogenesis using embryonic stem cell-derived endothelial cells. |
| Q40580539 | In vivo inhibition of tumor angiogenesis by a soluble VEGFR-2 fragment |
| Q40722597 | Induction of astrocyte differentiation by endothelial cells. |
| Q36349894 | Induction of pulmonary hypertension by an angiopoietin 1/TIE2/serotonin pathway |
| Q42077907 | Inflammation-induced intussusceptive angiogenesis in murine colitis |
| Q38333228 | Inhibition of VEGF receptors significantly impairs mammary cancer growth in C3(1)/Tag transgenic mice through antiangiogenic and non-antiangiogenic mechanisms |
| Q35298543 | Inhibition of angiogenesis by NSAIDs: molecular mechanisms and clinical implications |
| Q44352273 | Inhibition of angiogenesis by a Semliki Forest virus vector expressing VEGFR-2 reduces tumour growth and metastasis in mice. |
| Q53387216 | Inhibition of the mammary carcinoma angiogenic switch in C3(1)/SV40 transgenic mice by a mutated form of human endostatin. |
| Q43788142 | Integrin activation is required for VEGF and FGF receptor protein presence on human microvascular endothelial cells |
| Q40211907 | Integrin regulation by vascular endothelial growth factor in human brain microvascular endothelial cells: role of alpha6beta1 integrin in angiogenesis |
| Q74489334 | Intercellular communication between vascular smooth muscle and endothelial cells mediated by heparin-binding epidermal growth factor-like growth factor and vascular endothelial growth factor |
| Q34766063 | Interleukin-1--a major pleiotropic cytokine in tumor-host interactions |
| Q35049601 | Intussusceptive angiogenesis--the alternative to capillary sprouting |
| Q34349419 | Intussusceptive angiogenesis: its emergence, its characteristics, and its significance. |
| Q40109704 | Is a swine model of arteriovenous malformation suitable for human extracranial arteriovenous malformation? A preliminary study |
| Q35754557 | Is angiopoietin-2 necessary for the initiation of tumor angiogenesis? |
| Q35060001 | Isolation and purification of recombinant human plasminogen Kringle 5 by liquid chromatography and ammonium sulfate salting-out |
| Q46862943 | KLF2 transcription factor modulates blood vessel maturation through smooth muscle cell migration |
| Q73671410 | Kaposiform hemangioendothelioma associated with Milroy's disease (primary hereditary lymphedema) |
| Q40762762 | Ligand-targeted liposomes |
| Q38455525 | Linifanib: current status and future potential in cancer therapy |
| Q24298127 | Lipid phosphate phosphatase 3 stabilization of beta-catenin induces endothelial cell migration and formation of branching point structures |
| Q41199265 | Lymphangiogenesis and angiogenesis during human fetal pancreas development |
| Q50921659 | Male-specific cell migration into the developing gonad. |
| Q34479986 | Matrix metalloproteinases regulate neovascularization by acting as pericellular fibrinolysins |
| Q28507667 | Mekk3 is essential for early embryonic cardiovascular development |
| Q35669246 | Mesenchymal adenomatous polyposis coli plays critical and diverse roles in regulating lung development |
| Q36465519 | Methionine aminopeptidase-2 blockade reduces chronic collagen-induced arthritis: potential role for angiogenesis inhibition |
| Q46830786 | Micro-vessel density and the expression of vascular endothelial growth factor (VEGF) and platelet-derived endothelial cell growth factor (PdEGF) in classical Hodgkin lymphoma (HL). |
| Q47292754 | Microtubule depolymerization rapidly collapses capillary tube networks in vitro and angiogenic vessels in vivo through the small GTPase Rho. |
| Q30930218 | Microvascular Response in the Periodontal Ligament Following Mucoperiosteal Flap Surgery |
| Q33696723 | Molecular angiogenesis |
| Q35842085 | Molecular determinants of ovarian cancer plasticity |
| Q24336334 | Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4 |
| Q36766808 | Molecular mechanisms of pulmonary vascular development |
| Q46372754 | Molecular profile of endothelial invasion of three-dimensional collagen matrices: insights into angiogenic sprout induction in wound healing |
| Q35747435 | Molecular profiling of angiogenesis markers. |
| Q33318187 | Monitoring of the biological response to murine hindlimb ischemia with 64Cu-labeled vascular endothelial growth factor-121 positron emission tomography |
| Q34033506 | Morphine suppresses tumor angiogenesis through a HIF-1alpha/p38MAPK pathway |
| Q47711705 | Morphine: double-faced roles in the regulation of tumor development. |
| Q36704656 | Multifunctional antimicrobial peptides: therapeutic targets in several human diseases |
| Q37374995 | Mutant endoglin in hereditary hemorrhagic telangiectasia type 1 is transiently expressed intracellularly and is not a dominant negative |
| Q28509922 | NG2 proteoglycan is expressed exclusively by mural cells during vascular morphogenesis |
| Q49912474 | Neovasculature can be induced by patching an arterial graft into a vein: A novel in vivo model of spontaneous arteriovenous fistula formation |
| Q46857074 | Nerve growth factor is critical requirement for in vitro angiogenesis in gastric endothelial cells |
| Q77381667 | Neuroectodermal origin of brain pericytes and vascular smooth muscle cells |
| Q24322602 | Neurofibroma-associated growth factors activate a distinct signaling network to alter the function of neurofibromin-deficient endothelial cells |
| Q35357768 | Neuroprotective effect of the hairy root extract of Angelica gigas NAKAI on transient focal cerebral ischemia in rats through the regulation of angiogenesis |
| Q33813333 | Neurorestorative therapy for stroke |
| Q33739301 | New model of tumor angiogenesis: dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF. |
| Q33796246 | New paradigms of signaling in the vasculature: ephrins and metalloproteases |
| Q46848207 | Nonoverlapping expression patterns of ALK1 and ALK5 reveal distinct roles of each receptor in vascular development |
| Q29620377 | Notch signaling is essential for vascular morphogenesis in mice |
| Q36876705 | Notch signalling pathways mediate synovial angiogenesis in response to vascular endothelial growth factor and angiopoietin 2 |
| Q48483510 | Notch1 and Jagged1 expression by the developing pulmonary vasculature |
| Q37681157 | Novel aspects of corneal angiogenic and lymphangiogenic privilege. |
| Q64107734 | Novel thienopyrimidine derivatives as dual EGFR and VEGFR-2 inhibitors: design, synthesis, anticancer activity and effect on cell cycle profile |
| Q44119994 | Optimality in the developing vascular system: branching remodeling by means of intussusception as an efficient adaptation mechanism |
| Q34847842 | Orphan nuclear receptor TR3/Nur77 improves wound healing by upregulating the expression of integrin β4 |
| Q60652026 | Overexpression of vascular endothelial growth factor (VEGF) and its cellular receptor KDR (VEGFR-2) in the bone marrow of patients with acute myeloid leukemia |
| Q40352220 | Pascual-Castroviejo type II syndrome (P-CIIS). Importance of the presence of persistent embryonic arteries. |
| Q34312222 | Pathological angiogenesis is reduced by targeting pericytes via the NG2 proteoglycan |
| Q73140029 | Pathophysiologic significance of growth factors and new therapeutic concepts in cardiovascular disease |
| Q85041628 | Pathophysiology of portal hypertension, what's new? |
| Q27008071 | Pericyte dynamics during angiogenesis: new insights from new identities |
| Q36695062 | Pericytes on the tumor vasculature: jekyll or hyde? |
| Q39528556 | Perinatal lethality and endothelial cell abnormalities in several vessel compartments of fibulin-1-deficient mice |
| Q59050084 | Peritoneal Membrane Injury and Peritoneal Dialysis |
| Q36943828 | Peroxisome proliferator-activated receptor-β/δ regulates angiogenic cell behaviors and oxygen-induced retinopathy |
| Q42815983 | Pharmacological reactivity of neoplastic and non-neoplastic associated neovasculature to vasoconstrictors |
| Q37116110 | Phosphatidylinositol 3-kinase signaling mediates angiogenesis and expression of vascular endothelial growth factor in endothelial cells |
| Q44315020 | Photoreceptor-specific overexpression of platelet-derived growth factor induces proliferation of endothelial cells, pericytes, and glial cells and aberrant vascular development: an ultrastructural and immunocytochemical study |
| Q36419956 | Physical nanoscale conduit-mediated communication between tumour cells and the endothelium modulates endothelial phenotype |
| Q44957244 | Platelet-derived VEGF, Flt-1, angiopoietin-1 and P-selectin in breast and prostate cancer: further evidence for a role of platelets in tumour angiogenesis |
| Q35788469 | Platelet-derived growth factor B-chain of hematopoietic origin is not necessary for granulation tissue formation and its absence enhances vascularization |
| Q28569874 | Platelet-derived growth factors and receptors in the rat corpus luteum: localization and identification of an effect on luteogenesis |
| Q51055110 | Platelet-rich plasma releasate promotes angiogenesis in vitro and in vivo. |
| Q49441016 | Plocabulin, a novel tubulin-binding agent, inhibits angiogenesis by modulation of microtubule dynamics in endothelial cells |
| Q28512594 | Polycystin 1 is required for the structural integrity of blood vessels |
| Q77106419 | Polymeric system for dual growth factor delivery |
| Q35481103 | Polymorphisms of COL4A1 gene are associated with arterial pulse wave velocity in healthy Han Chinese and Uygur subjects |
| Q28237341 | Population pharmacokinetics of sibrotuzumab, a novel therapeutic monoclonal antibody, in cancer patients |
| Q38164468 | Possible role of local hypoxia in the de novo formation of dural and osteodural arteriovenous fistulas after encephalitis. A case report. |
| Q35842264 | Potential role of modifier genes influencing transforming growth factor-beta1 levels in the development of vascular defects in endoglin heterozygous mice with hereditary hemorrhagic telangiectasia. |
| Q47178452 | Predicting the survival of patients with breast carcinoma using tumor size |
| Q36694709 | Prediction of metastasis risk (11 year follow-up) using VEGF-R1, VEGF-R2, Tie-2/Tek and CD105 expression in breast cancer (n=905). |
| Q37428029 | Preeclampsia and small-for-gestational age are associated with decreased concentrations of a factor involved in angiogenesis: soluble Tie-2. |
| Q28142311 | Prenatal origins of human intrapulmonary arteries: formation and smooth muscle maturation |
| Q34973747 | Principals of neovascularization for tissue engineering |
| Q38406281 | Prostate-specific membrane antigen regulates angiogenesis by modulating integrin signal transduction |
| Q37234135 | Proteomic profiling of endothelial invasion revealed receptor for activated C kinase 1 (RACK1) complexed with vimentin to regulate focal adhesion kinase (FAK) |
| Q41000446 | Prothrombin kringle-2 domain has a growth inhibitory activity against basic fibroblast growth factor-stimulated capillary endothelial cells |
| Q35783072 | Quantitative mapping of tumor vascularity using volumetric contrast-enhanced ultrasound |
| Q35810167 | RGD-dependent vacuolation and lumen formation observed during endothelial cell morphogenesis in three-dimensional fibrin matrices involves the alpha(v)beta(3) and alpha(5)beta(1) integrins |
| Q28258068 | Rebamipide activates genes encoding angiogenic growth factors and Cox2 and stimulates angiogenesis: a key to its ulcer healing action? |
| Q34808162 | Recent advances in cutaneous angiogenesis |
| Q39740070 | Recombinant angiopoietin-1 restores higher-order architecture of growing blood vessels in mice in the absence of mural cells. |
| Q34601093 | Recruitment and activation of phospholipase Cgamma1 by vascular endothelial growth factor receptor-2 are required for tubulogenesis and differentiation of endothelial cells |
| Q55516773 | Reduced NGF in Gastric Endothelial Cells Is One of the Main Causes of Impaired Angiogenesis in Aging Gastric Mucosa. |
| Q34398013 | Regeneration of gastric mucosa during ulcer healing is triggered by growth factors and signal transduction pathways |
| Q35925032 | Regulation of COX-2 mediated signaling by alpha3 type IV noncollagenous domain in tumor angiogenesis. |
| Q40519169 | Regulation of VEGF-A, VEGFR-I, thrombospondin-1, -2, and -3 expression in a human pituitary cell line (HP75) by TGFbeta1, bFGF, and EGF. |
| Q35789129 | Regulation of angiogenesis by vascular endothelial growth factor and angiopoietin-1 in the rat aorta model: distinct temporal patterns of intracellular signaling correlate with induction of angiogenic sprouting |
| Q58594935 | Relationship between VEGF-related gene polymorphisms and brain morphology in treatment-naïve patients with first-episode major depressive disorder |
| Q45791189 | Relationship between gingival angiopoietin-1 concentrations and depth of the adjacent gingival sulcus |
| Q83228101 | Relationship between prostaglandin E2 and vascular endothelial growth factor (VEGF) in angiogenesis in human vascular endothelial cells |
| Q28365924 | Rescue of the early vascular defects in Tek/Tie2 null mice reveals an essential survival function |
| Q80678101 | Reversal of portal hypertension and hyperdynamic splanchnic circulation by combined vascular endothelial growth factor and platelet-derived growth factor blockade in rats |
| Q36680668 | Review of the pericyte during angiogenesis and its role in cancer and diabetic retinopathy |
| Q37934234 | Review paper: critical issues in tissue engineering: biomaterials, cell sources, angiogenesis, and drug delivery systems |
| Q33845292 | Role of cytosolic phospholipase A(2) in retinal neovascularization |
| Q36530328 | Role of hematopoietic lineage cells as accessory components in blood vessel formation |
| Q34448193 | Role of hematopoietic stem cells in angiogenesis |
| Q37903938 | Role of intimate interactions between endothelial cells and the surrounding accessory cells in the maturation of blood vessels |
| Q35668936 | Roles of main pro- and anti-angiogenic factors in tumor angiogenesis |
| Q33837107 | Selective role of a distinct tyrosine residue on Tie2 in heart development and early hematopoiesis |
| Q43859324 | Semi-automated method of quantifying vasculature of 1-methyl-1-nitrosourea-induced rat mammary carcinomas using immunohistochemical detection |
| Q46623662 | Sensory nerves determine the pattern of arterial differentiation and blood vessel branching in the skin |
| Q24295052 | Serum response factor is a critical requirement for VEGF signaling in endothelial cells and VEGF-induced angiogenesis |
| Q91967500 | Sex differences in cancer mechanisms |
| Q41750930 | Signaling angiogenesis and lymphangiogenesis |
| Q55281505 | Signalling by Transforming Growth Factor Beta Isoforms in Wound Healing and Tissue Regeneration |
| Q38304360 | Signalling properties of an HIV-encoded angiogenic peptide mimicking vascular endothelial growth factor activity. |
| Q28204868 | Signals transduced by Ca(2+)/calcineurin and NFATc3/c4 pattern the developing vasculature |
| Q30819009 | Snake venom disintegrin, saxatilin, inhibits platelet aggregation, human umbilical vein endothelial cell proliferation, and smooth muscle cell migration |
| Q34878780 | Soluble and insoluble signals sculpt osteogenesis in angiogenesis |
| Q91404780 | Sorsby Fundus Dystrophy Mutation in Tissue Inhibitor of Metalloproteinase 3 (TIMP3) promotes Choroidal Neovascularization via a Fibroblast Growth Factor-dependent Mechanism |
| Q38416404 | Spatiotemporal mapping of vascularization and innervation in the fetal murine intestine. |
| Q36181388 | Sphingosine-1-phosphate: an emerging therapeutic target |
| Q28305641 | Src regulates angiogenic factors and vascular permeability after focal cerebral ischemia-reperfusion |
| Q36644117 | Stabilization of breast cancer xenograft tumour neovasculature by angiopoietin-1. |
| Q47579335 | Structural and biophysical simulation of angiogenesis and vascular remodeling |
| Q35934057 | Structural and functional characterization of two alternative splicing variants of mouse Endothelial Cell-Specific Chemotaxis Regulator (ECSCR) |
| Q27677414 | Structural basis for angiopoietin-1-mediated signaling initiation |
| Q33861490 | Suppression of angiogenesis and tumor growth by the inhibitor K1-5 generated by plasmin-mediated proteolysis |
| Q34414642 | Suppressor and oncogenic roles of transforming growth factor-beta and its signaling pathways in tumorigenesis |
| Q28145776 | Symmetrical mutant phenotypes of the receptor EphB4 and its specific transmembrane ligand ephrin-B2 in cardiovascular development |
| Q47073468 | Syndecan-2 is essential for angiogenic sprouting during zebrafish development |
| Q52865453 | Synovial cytokine and growth factor regulation of MMPs/TIMPs: implications for erosions and angiogenesis in early rheumatoid and psoriatic arthritis patients. |
| Q42917997 | TGF-beta receptor kinase inhibitor enhances growth and integrity of embryonic stem cell-derived endothelial cells |
| Q37359962 | TGF-beta signaling in vascular biology and dysfunction |
| Q44486162 | Targeted disruption of endothelial cell-selective adhesion molecule inhibits angiogenic processes in vitro and in vivo |
| Q37089056 | Targeting cancer stem cells to modulate alternative vascularization mechanisms. |
| Q30355907 | Targeting pericytes for angiogenic therapies. |
| Q37767356 | Targeting the tumour vasculature: insights from physiological angiogenesis |
| Q24632012 | Temporal profile of Src, SSeCKS, and angiogenic factors after focal cerebral ischemia: correlations with angiogenesis and cerebral edema |
| Q38301216 | The 3T3-L1 fibroblast to adipocyte conversion is accompanied by increased expression of angiopoietin-1, a ligand for tie2. |
| Q34020783 | The Arf tumor suppressor gene promotes hyaloid vascular regression during mouse eye development |
| Q33765926 | The Effect of Interleukin 38 on Angiogenesis in a Model of Oxygen-induced Retinopathy |
| Q24604636 | The LKLF transcription factor is required for normal tunica media formation and blood vessel stabilization during murine embryogenesis |
| Q34509167 | The Molecular Signatures Database (MSigDB) hallmark gene set collection |
| Q38948602 | The Role of Interleukin-1 in Inflammatory and Malignant Human Skin Diseases and the Rationale for Targeting Interleukin-1 Alpha |
| Q28586248 | The ShcA phosphotyrosine docking protein sensitizes cardiovascular signaling in the mouse embryo |
| Q73955109 | The angiopoietins, tie2 and vascular endothelial growth factor are differentially expressed in the transformation of normal lung to non-small cell lung carcinomas |
| Q37621662 | The axonal attractant Netrin-1 is an angiogenic factor. |
| Q33838096 | The basic helix-loop-helix transcription factor, dHAND, is required for vascular development |
| Q34498192 | The blood-brain barrier and cerebral angiogenesis: lessons from the cold-injury model |
| Q28504884 | The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract |
| Q54342105 | The effects of sorafenib on the portal hypertensive syndrome in patients with liver cirrhosis and hepatocellular carcinoma--a pilot study. |
| Q38678569 | The emerging role of interleukin-37 in cardiovascular diseases |
| Q46699319 | The ephrin-A1 ligand and its receptor, EphA2, are expressed during tumor neovascularization |
| Q28137728 | The expression of Jagged1 in the developing mammalian heart correlates with cardiovascular disease in Alagille syndrome |
| Q28504785 | The membrane-anchored MMP inhibitor RECK is a key regulator of extracellular matrix integrity and angiogenesis |
| Q41716944 | The molecular and cellular biology of the chemokines |
| Q36176445 | The origin of the endothelial cells: an evo-devo approach for the invertebrate/vertebrate transition of the circulatory system. |
| Q24605541 | The orphan nuclear receptor COUP-TFII is required for angiogenesis and heart development |
| Q44002704 | The presence of a single tyrosine residue at the carboxyl domain of vascular endothelial growth factor receptor-2/FLK-1 regulates its autophosphorylation and activation of signaling molecules |
| Q37683553 | The role IL-1 in tumor-mediated angiogenesis |
| Q37907914 | The role of morphine in regulation of cancer cell growth |
| Q35067253 | The role of prolactin in mammary carcinoma |
| Q38084327 | The role of skin substitutes in the management of chronic cutaneous wounds. |
| Q37259779 | The role of the NFAT signaling pathway in retinal neovascularization. |
| Q46528698 | The roles of endoglin gene in cerebrovascular diseases |
| Q39759735 | Therapeutic angiogenesis by intramuscular injection of fibrin particles into ischaemic hindlimbs |
| Q73580422 | Therapeutic prospects for PEDF: more than a promising angiogenesis inhibitor |
| Q35787736 | Three-dimensional reconstruction of pulmonary arteries in plexiform pulmonary hypertension using cell-specific markers. Evidence for a dynamic and heterogeneous process of pulmonary endothelial cell growth |
| Q30786866 | Three-dimensional study of the capillary supply of skeletal muscle fibres using confocal microscopy |
| Q34351456 | Thrombospondins and tumor angiogenesis |
| Q48308816 | Time- and cell type-specific induction of platelet-derived growth factor receptor-beta during cerebral ischemia. |
| Q35152040 | Tissue inhibitor of metalloproteinase-3 (TIMP3) promotes endothelial apoptosis via a caspase-independent mechanism |
| Q45065838 | Transformation of vascular endothelial cells by a point mutation in the Tie2 gene from human intramuscular haemangioma |
| Q73379080 | Transforming growth factor beta2 inhibition of hepatocyte growth factor-induced endothelial proliferation and migration |
| Q92677820 | Transient Receptor Potential Channels and Endothelial Cell Calcium Signaling |
| Q77159735 | Transplantation of adrenocortical cells |
| Q33775917 | Treatment of dural arteriovenous malformations and fistulas. |
| Q35072701 | Tryptanthrin inhibits angiogenesis by targeting the VEGFR2-mediated ERK1/2 signalling pathway |
| Q34069060 | Tumor angiogenesis: molecular pathology, therapeutic targeting, and imaging |
| Q58352361 | Tumour vascular endothelial growth factor (VEGF) mRNA in relation to serum VEGF protein levels and tumour progression in human renal cell carcinoma |
| Q28645569 | Tyrosine 1101 of Tie2 is the major site of association of p85 and is required for activation of phosphatidylinositol 3-kinase and Akt |
| Q36028146 | Understanding angiogenesis: a clue for understanding vascular malformations. |
| Q42049314 | VEGF induces cardiovascular malformation and embryonic lethality |
| Q53305892 | VEGF stimulates PKD-mediated CREB-dependent orphan nuclear receptor Nurr1 expression: role in VEGF-induced angiogenesis. |
| Q28200072 | VEGF-D promotes the metastatic spread of tumor cells via the lymphatics |
| Q39378135 | VEGFR-2 inhibitors and the therapeutic applications thereof: a patent review (2012-2016). |
| Q78881009 | VEGFR-2-specific ligand VEGF-E induces non-edematous hyper-vascularization in mice |
| Q43240879 | VEGI-armed oncolytic adenovirus inhibits tumor neovascularization and directly induces mitochondria-mediated cancer cell apoptosis |
| Q34012125 | Vascular anomalies |
| Q52165379 | Vascular developmental biology: getting nervous. |
| Q35748093 | Vascular morphogenesis and differentiation after adoptive transfer of human endothelial cells to immunodeficient mice |
| Q35066911 | Vascularization of the developing chick limb bud: role of the TGFbeta signalling pathway |
| Q92257481 | Vascularized Microfluidics and the Blood-Endothelium Interface |
| Q37768939 | Vasculogenesis and angiogenesis: molecular and cellular controls. Part 1: growth factors |
| Q33869959 | Vasculogenesis driven by bone marrow-derived cells is essential for growth of Ewing's sarcomas |
| Q47964362 | Vasculogenesis, angiogenesis, and growth factors: ephrins enter the fray at the border |
| Q48498177 | Vessel co-option: how tumors obtain blood supply in the absence of sprouting angiogenesis |
| Q34395548 | Vimentin as an integral regulator of cell adhesion and endothelial sprouting |
| Q45874860 | Viral vector-mediated transduction of a modified thrombospondin-2 cDNA inhibits tumor growth and angiogenesis |
| Q36708636 | WNK1 protein kinase regulates embryonic cardiovascular development through the OSR1 signaling cascade |
| Q45258871 | Wound healing and cancer progression in Opisthorchis viverrini associated cholangiocarcinoma. |
| Q48037302 | Xenopus eHAND: a marker for the developing cardiovascular system of the embryo that is regulated by bone morphogenetic proteins |
| Q28592571 | Yolk sac angiogenic defect and intra-embryonic apoptosis in mice lacking the Ets-related factor TEL |
| Q42518650 | Zone-specific remodeling of tumor blood vessels affects tumor growth |
| Q35936630 | Zymographic evaluation of plasminogen activators and plasminogen activator inhibitors. |
| Q77886984 | [Angiomas and major tissue dysplasias. Pathogenic origins and management] |
| Q73338644 | [Angiomas in children at a turning point of understanding and management] |
| Q52113714 | [The epicardium and epicardial-derived cells: multiple functions in cardiac development]. |
| Q55068203 | [Tumoral angiogenesis: physiopathology, prognostic value and therapeutic perspectives]. |
| Q77488091 | [Vascular endothelial growth factor-induced cardiovascular malformations in embryo development] |
Search more.